0药明康德“中途下车”,是无奈还是不看好?药明康德全面“退出”Guide View据经济参考报消息,继去年底出售海外细胞和基因治疗业务外,药明康德再度出售国内相关业务。7月20日,记者查询天眼查数据发现,无锡生基医药科技有限公司(简称“无锡生基”)股权近日已由药明康德变更为“上海基未科技有限公司”(简称“上海基未”),股权层层穿透后,无锡生基实际控制人指向IDG资本合伙人李建光,四川双马(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.